InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,594.77
(
-1.28%
)
US TECH 100
19,326.80
(
-2.65%
)
Dow Jones
41,153.04
(
0.48%
)
Brent Oil
84.40
(
1.30%
)
Bitcoin
64,316.56
(
-1.18%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DarkKnight83

Send PM Follow Ignore
Followers 83
Posts 4211
Boards Moderated 0
Alias Born 03/29/2012

DarkKnight83

Re: None

Saturday, 02/23/2013 12:06:02 PM

Saturday, February 23, 2013 12:06:02 PM

Post# of 158400
Restructuring
On February 1, 2011, Pfizer announced plans to restructure its R&D operations. Overall the company plans to take $1.5 billion out of its drug research programs and use the proceeds to fund a $5 billion dollar stock repurchase program. The reduction in R&D was driven by a decision to reduce the number of disease areas the company will focus on.

Pfizer has announced plans to shift its research and development focus away from heart disease drugs to cancer and biotechnology drugs, which it says are more profitable. The former category includes the company's most profitable product, Lipitor.

$$$Bwhahahaa! BMSN Lookin Good!$$$$

http://www.wikinvest.com/stock/Pfizer_(PFE)
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up